Micropigmentation for vitiligo on light to moderately colored skin: Updated evidence from a clinical and animal study. Issue 5 (2nd March 2020)

• Record Type: Journal Article
• Authors: Ju, Hyun Jeong; Eun, Sung Hye; Lee, Han Na; Lee, Ji Hae; Kim, Gyong Moon; Bae, Jung Min
• Is Part Of: Journal of dermatology. Volume 47:Issue 5(2020)
• Page Start: 464
• Page End: 469
• Publication Date: 2020-03-02
• Subjects: camouflage -- intervention -- medical tattooing -- pigment -- surgery -- vitiligo; Dermatology -- Periodicals; Dermatology -- Japan -- Periodicals; Skin -- Diseases -- Periodicals; 616.5005
• DOI: 10.1111/1346-8138.15282
• Languages: English
• ISSNs: 0385-2407

Abstract

Abstract: Micropigmentation, also termed medical tattooing, can be a useful alternative treatment for patients with vitiligo who are resistant to conventional treatments. To assess the benefits and risks of micropigmentation in the treatment of refractory vitiligo, 25 lesions of 14 patients with vitiligo (Fitzpatrick skin types III and IV) were subjected to micropigmentation using an electric tattooing machine between December 2018 and March 2019. The procedure was repeated until satisfactory results were obtained. Treatment response was assessed by color matching of the treated lesion and surrounding skin using a 4‐point scale (poor, fair, good and excellent). Excellent color matching was achieved in 80% (20/25) of cases after a median of three (range, 1–5) treatment sessions. Procedure‐associated pain was considerable, but no anesthetic injection was needed. Immediate erythema and swelling were noticed after each procedure, but resolved within a few days. Overall, the treatment was tolerable. This study was limited by a small sample, no control group and a short follow‐up period. This study revealed that micropigmentation was beneficial for patients with refractory vitiligo who had light to moderately colored skin. Pigment selection, implantation depth and selection of body parts amenable to treatment were critical.